GM-CSF effects on immune cells have been documented in inflammatory diseases of the lung (e.g., influenza virus and aPAP) and GI tract (e.g., Crohn’s) and may play a role in checkpoint-induced pneumonitis and immune-mediated colitis (6, 11, 30). Here, CSF2 is linked to pneumonitis.